Zyprexa Whistleblower Wants To Switch Courts

By Erin Marie Daly

Law360, New York (October 19, 2007, 12:00 AM ET) -- A former Eli Lilly & Co. employee has sought to remove her whistleblower suit over allegations that the pharmaceutical giant marketed its blockbuster anti-psychotic drug Zyprexa for off-label uses to a California superior court, saying Lilly cannot demonstrate that her state law claims invoke “substantial federal questions.”

In court documents filed Friday in the U.S. District Court for the Northern District of California, plaintiff Jaydeen Vincente said that Lilly's removal of the case from San Francisco Superior Court in September based on federal question jurisdiction lacks...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles